7 Results for "

pan+fgfr+inhibitor

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "pan+fgfr+inhibitor" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-13304
CAS No.: 1254473-64-7
Purity:  99.14%
Target:  

FGFR

Research Areas:  

Cancer

LY2874455 is a pan-FGFR inhibitor with IC50s of 2.8, 2.6, 6.4, 6 nM for FGFR1, FGFR2, FGFR3, FGFR4, respectively.
loading...
    loading...
Cat. No.: HY-178059
Target:  

FGFR p38 MAPK Akt ERK Apoptosis

Research Areas:  

Cancer

FGFR-IN-23 (Compound 9p) is a covalent pan FGFR inhibitor with IC50s of 14, 4.2, 5 and 220 nM for FGFR1, FGFR2, FGFR3 and FGFR4, respectively. FGFR-IN-23 also has potent inhibitory activity against gatekeeper mutants, such as FGFR1 V561M and FGFR3 V555M. FGFR-IN-23 suppresses the activation of FGFR-mediated signaling and induces apoptosis. FGFR-IN-23 shows significant antitumor efficacy in RT112 xenograft mouse models. FGFR-IN-23 can be used for cancers and its drug resistance research .
loading...
    loading...
Cat. No.: HY-160124
CAS No.: 2504949-83-9
Target:  

FGFR

Research Areas:  

Cancer

Infigratinib-Boc is a derivative of Infigratinib containing a Boc (t-Butyloxy carbonyl) group. Infigratinib is an ATP-competitive pan-FGFR inhibitor .
loading...
    loading...
Cat. No.: HY-168653
Target:  

FGFR

Research Areas:  

Cancer

FGFR-IN-15 (compound 18i) is a pan-FGFR inhibitor with potently inhibitory activity against FGFR1-4. .
loading...
    loading...
Cat. No.: HY-147715
CAS No.: 2428738-41-2
Target:  

FGFR

Research Areas:  

Cancer

FGFR3-IN-3 (compound 40a) is a potent and pan-FGFR inhibitor, with IC50s of 2.1 nM, 3.1 nM, 4.3 nM and 74 nM for FGFR1, 2, 3, and 4, respectively. FGFR3-IN-3 can be used for the research of bladder cancer .
loading...
    loading...
Cat. No.: HY-162577
CAS No.: 3047446-75-0
Target:  

FGFR

Research Areas:  

Cancer

FGFR-IN-14 (compound 10h) is a pan-FGFR inhibitor. FGFR-IN-14 inhibits FGFR1, FGFR2, FGFR3 and FGFR2 V564F gatekeeper mutant with IC50s of 46, 41, 99, and 62 nM, respectively. FGFR-IN-14 strongly suppresses NCI-H520 lung cancer cells, SNU-16 and KATO III gastric cancer cells proliferation with IC50s of 19, 59, and 73 nM, respectively .
loading...
    loading...
Cat. No.: HY-189241
Target:  

FGFR

Research Areas:  

Cancer

FGFR-IN-29 is an orally active pan-FGFR inhibitor that suppresses the kinase activities of FGFR1, FGFR2, FGFR3, and FGFR4. FGFR-IN-29 blocks the intracellular phosphorylation process of FGFR and arrests downstream tumor cell proliferation signaling. FGFR-IN-29 inhibits tumor growth in solid tumor xenograft mouse models. FGFR-IN-29 is applicable for cancer-related research .
loading...
    loading...